SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rupee strengthens against US dollar on Wednesday

15 Jul 2020 Evaluate

Indian rupee strengthened against the US dollar on Wednesday, tracking gains in the domestic equity market after the human clinical trials for corona virus vaccine were initiated in India. The Indian Council of Medical Research said human clinical trials for a potential vaccine for corona virus had been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates. The Drugs Controller General of India has permitted two vaccines, one developed by Bharat Biotech International in collaboration with ICMR and another one by Zydus Cadila Healthcare to go in for the first and second phase of human clinical trials. Further, weakness in American currency too supported the rupee, though foreign fund outflows and fears over rising corona virus cases weighed on investor sentiment and restricted rupee gains. Foreign Institutional Investors (FIIs) sold shares worth Rs 1,565.62 crore on Tuesday, exchange data showed. Health ministry data showed the death toll in India due to corona virus rose to 24,309 and the number of infections spiked to 9,36,181, while the number of cases around the world has crossed 1.32 crore with death toll topped at 5.77 lakh.

The partially convertible currency is currently trading at 75.29, stronger by 13 paise from its previous close of 75.42 on Tuesday. The currency touched a high and low of 75.3550 and 75.2450 respectively. The reference rate for the dollar stood at 75.15 and for Euro stood at 85.12 on July 13, 2020. While the reference rate for the Yen stood at 70.30, the reference rate for the Great Britain Pound (GBP) stood at 95.11.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×